| 摘要 |
The present invention relates to compositions and methods relating to the characterization and function of Kv1.7. Specifically, the present invention provides transgenic animals and methods of treating diseases conditions, such as diabetes, obesity, anxiety and pain. The present invention further relates to agents that modulate Kv1.7 and methods of screening for agents that modulate Kv1.7 for the treatment of diseases and conditions such as diabetes, obesity, anxiety and pain.
|
